All Type of News
Drinkable arthritis agents to need more time to settle in market
It seems the ‘drinkable arthritis treatment’ which recently landed in Korea needs more time to settle in the market. Its sales were only less than KRW 500 million in the first half of the year.
According to the pharm...
LG Life Sciences expect merger with LG ChemA merger of two companies, LG Life Sciences and LG Chem, is expected to be pushed.
On the 6th, LG Chem and LG Life Sciences officially announced they have not currently decided...
|
Hepatitis B treatment, Baraclude’s drug price cut from the 7th
From the 7th, the upper health insurance benefit of the BMS Pharmaceutical Korea’s(CEO Hye-sun Park) chronic hepatitis B treatment, Baraclude(generic name: entecavir), will be lowered to 53.55% of the original price b...
Domestic companies’ new trend to recruit directors with experience at multinational company
Along with popularity of expansion in global businesses and evidence-based academic marketing, domestic pharmaceutical companies have started to change their employment patterns.
Domestic pharmaceutical companies hav...
Multinational companies, “It is hard to find a Korean company not owning competing drugs”
“It is hard to select a partner since all the candidate companies have too many co-marketed products.”
Marketers at multinational pharmaceutical companies which are preparing to strengthen marketing for existing drug...
Active process to nullify rapidly-grown ‘Eiliquis’ & ‘Pradaxa’ patents
Domestic pharmaceutical companies will challenge the patent wall of novel oral anticoagulants(NOACs), ‘Pradaxa’ and ‘Eliquis.’ They are also trying to nullify the ‘Brilinta’ patent as well.
According to the pharmaceu...
Pharmaceutical distribution industry ignorant of Kim Young-ran Law
Facing the enforcement of the ‘Anti-Corruption and Bribery Prohibition Law,’ also known as ‘Kim Young-ran Law,’ on the 28th of September, the pharmaceutical industry is giving the best on its advanced prevention, such...
How their own employees think about enviable foreign pharmaceutical companies?
“We have too much overtime at night at Pfizer.” “Novartis blames on employees when an issue occurs.”
‘Foreign pharmaceutical companies’ are companies that pharmacy students, medical students and distinguished univers...
2nd golden age in insulin market with ‘Toujeo & Tresiba’
Difficulties as an injection and side effects such as hypoglycemia and weight increase…
The basal insulin market which used be considered as headache only 1-2 years ago is having the second golden age with Toujeo and...
Competition to preoccupy Viread generic market of KRW 150 billion
It’s Viread for now. After Baraclude generics, domestic pharmaceutical companies are directly aiming for Viread whose substance patent is expiring soon on November next year.
Viread is a product which become the larg...
